|
|
Article: Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic.
- Article from:
- PR Newswire
- Article date:
- January 4, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOSTON, Jan. 4 /PRNewswire/ -- Follica Inc., a privately held developer of a novel therapy for androgenetic alopecia (male and female pattern hair loss caused by androgens in genetically susceptible men and women) and other hair follicle disorders, today announced a $5.5 million Series A financing round. Interwest Partners led the financing and existing investors PureTech Ventures participated. The funding is expected to take the company through a clinical proof of concept study. Follica was co-founded by PureTech Ventures and a group of academic dermatologists from leading institutions such as Harvard, UCSF and the University of Pennsylvania to address the critical ...
Related newspaper, magazine, and journal articles:
|
|
Article: Potential baldness cure: genetic trickery could coax hair ...
Chemistry and Industry;
May 28, 2007 ;
700+ words
... ... intervention,' said Daphne Zohar, ceo of Follica, a private medical device company. 'During ... be billions,' said David Steinberg of PureTech Ventures. Follica, founded by PureTech Ventures in 2005, has exclusively licensed core ...
|
|